Compare · CBOE vs IBB
CBOE vs IBB
Side-by-side comparison of Cboe Global Markets, Inc. (CBOE) and iShares Nasdaq Biotechnology Index Fund (IBB): market cap, price performance, sector, and recent activity on the wire.
Summary
- CBOE operates in Finance, while IBB operates in n/a - the two are in different parts of the market.
- CBOE has hit the wire 7 times in the past 4 weeks while IBB has been quiet.
- CBOE has more recent analyst coverage (25 ratings vs 0 for IBB).
Cboe Global Markets, Inc.
Cboe Global Markets, Inc., through its subsidiaries, operates as an options exchange worldwide. It operates through five segments: Options, North American Equities, Futures, European Equities, and Global FX. The Options segment trades in listed market indices. The North American Equities segment trades in listed U.S. and Canadian equities; and offers exchange-traded products (ETP) transaction and ETP listing services. The Futures segment trades in futures. The European Equities segment offers pan-European listed equities transaction services, ETPs, exchange-traded commodities, and international depository receipts, as well as ETP listings and clearing services. The Global FX segment provides institutional foreign exchange (FX) trading and non-deliverable forward FX transactions services. The company has strategic relationships with S&P Dow Jones Indices, LLC; FTSE International Limited; Frank Russell Company; MSCI Inc.; and DJI Opco, LLC. The company was formerly known as CBOE Holdings, Inc. and changed its name to Cboe Global Markets, Inc. in October 2017. Cboe Global Markets, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.
iShares Nasdaq Biotechnology Index Fund
The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Latest CBOE
- Cboe Expands Prediction Markets Suite to Small-Caps with Launch of Mini-Russell 2000 Index Binary Options
- Director Tomczyk Fredric J gifted 920 shares, decreasing direct ownership by 3% to 34,711 units (SEC Form 4)
- Cboe Global Markets Reports Trading Volume for October 2026
- Cboe Joins Capital Markets Alliance Challenge to CFTC Approval of Single-Stock Perpetual Derivatives
- SEC Form 10-Q filed by Cboe Global Markets, Inc.
- Cboe Global Markets, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Cboe Global Markets Reports Results for Third Quarter 2026
- Cboe Clear U.S. Receives SEC Approval to Expand Clearing Capabilities
- Cboe Global Markets Announces Increase in Share Repurchase Authorization; Declares Fourth-Quarter 2026 Dividend
- Cboe Launches Extended Trading Sessions for Select Single Stock and ETF Options
Latest IBB
- Altimmune Added to Nasdaq Biotechnology Index
- Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
- Stocks Stalls As Chip Sector Struggles To Rebound; Dollar Eyes 7-Week Peak, Gold, Bitcoin Retreat: What's Driving Markets Friday?
- April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
- AI, Biotech, Energy Sectors Expect M&A Revival For 2024
- Live On CNBC, Jason Snipe's Contrarian Idea: Biotech; Names IShares Biotechnology ETF
- US Stocks Eye 3-Day Slump; Tech, Crypto Sell-Off Deepens, Oil, Dollar Rebound: What's Driving Markets Wednesday?
- Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday?
- Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback
- Wall Street Sees Post-Holiday Gains, Oil Rallies, Intel Leads: What's Driving Markets Tuesday?